• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    NIAID receives the FDA approval to conduct a phase 2 clinical trial with UB-421

    PRNEWSWIRE

    United BioPharma`s Study Reveals New Class of Monoclonal Antibody

    PRNEWSWIRE

    United BioPharma Receives TFDA Approval for PII IND for UB-221

    PRNEWSWIRE

    United , Shanghai Public Health Clinical Centre and Cheng Kung University UB-621

    PRNEWSWIRE

    United BioPharma Received IND Approval from China NMPA for UB-621 Ph2 Trial

    UNITEDBIOPHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.